This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 April 2023 and includes updates on mpox, Group A streptococcal, Influenza A(H5N1) infection, and Marburg virus disease.
This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the planning and implementation of COVID-19 vaccination campaigns for 2023.
To decrease the impact of COVID-19, and related hospitalisations and mortality, countries should plan for a continued roll-out of COVID vaccines in 2023.
The annual European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place in Barcelona and online from 22-24 November 2023.
Since April 2012, and as of 28 February 2023, a total of 2 613 cases of MERS-CoV, including 945 deaths, have been reported by health authorities worldwide
ECDC experts from Public Health Training visited the headquarters of the Africa Centres for Disease Control and Prevention (Africa CDC) in Addis Ababa, Ethiopia, from 3 to 5 April 2023 to establish a roadmap and practical procedures to produce, adapt, and translate learning content for Africa CDC.
ECDC has published the latest long-term surveillance framework that identifies concrete objectives, actions, targets and milestones to be achieved in surveillance of infectious diseases in the EU/EEA by 2027.